VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $27,705,000 | +8.6% | 1,740,258 | -2.2% | 1.74% | -31.3% |
| Q3 2017 | $25,508,000 | -17.2% | 1,780,069 | 0.0% | 2.54% | -33.3% |
| Q2 2017 | $30,796,000 | +109.3% | 1,780,069 | +33.4% | 3.80% | +106.9% |
| Q1 2017 | $14,713,000 | -45.3% | 1,333,923 | -28.0% | 1.84% | -49.0% |
| Q4 2016 | $26,916,000 | +261.0% | 1,853,708 | +510.4% | 3.60% | +330.9% |
| Q3 2016 | $7,456,000 | +37.8% | 303,708 | +13.8% | 0.84% | +59.8% |
| Q2 2016 | $5,410,000 | +23.1% | 266,970 | +59.8% | 0.52% | +67.1% |
| Q1 2016 | $4,394,000 | – | 167,100 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |